MolNFT v1 · #50582 · protein
Rmp-pepstatin a complex
2RMP · Mucoropepsin: “Rmp-pepstatin a complex”. X-ray diffraction, 3 ligands (IVA, NAG, BMA), 1 pocket (best druggability 0.32). MolNFT v1 #50582 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 2RMP
- Type
- protein
- Length
- 363 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Mucoropepsin; Pepstatin
- EC
- 3.4.23.23
- UniProt
- P00799
- Ligands
- IVA, NAG, BMA
- Pockets
- 1 · best druggability 0.32
Structure
x-ray diffraction · 2 distinct chains · 10% helix, 44% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Mucoropepsin (EC 3.4.23.23) | protein | 358 | 10% helix, 45% strand | P00799 |
| B | Pepstatin | protein | 5 | 0% helix, 0% strand | — |
Ligands and binding sites
- IVA · Isovaleric acid · ligand · chains A, B
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
- BMA · beta-D-mannopyranose · sugar
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 88 | 0.32 | 0.73 | 19 | empty |
Interfaces
1 interface between chains.
- A–B · 568 Ų buried · 10 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 disulfide, 2 glycan, 2 modified, 1 covalent (disulfide, N-glycosylation, nonstandard, covalent ligand).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00799
- Elsewhere: RCSB PDB 2RMP · PDBe 2RMP · UniProt P00799
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.